Chiesi   Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Parma Italy (1935)

Organization Overview

First Clinical Trial
2002
NCT00382889
First Marketed Drug
1988
nicardipine (cardene)
First NDA Approval
1996
reteplase (Retavase)
Last Known Activity
2023

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

CHIESI | Chiesi España | Chiesi Farmaceutici | Chiesi Farmaceutici S.p.A. | CHIESI FARMACEUTICI SPA | Chiesi GmbH | Chiesi Pharmaceuticals | Chiesi Slovenija, d.o.o. | Chiesi UK | Chiesi USA | Chiesi USA, Inc. | CHIESI USA INC | Innovair | Medical Department; Chiesi Farmaceutici S.p.A (Italy)